Finance

Lists
Why is OCS down 2,84%?
Dive Deeper
OCS:NASDAQ
Oculis Holding AG
7,54 $
-2,84%
(-0,22) 1D
10 նոյ, 15:08:45 GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for OCS...
Open
7,72 $
High
8,04 $
Low
7,54 $
Mkt. cap
466,87 մլն
Avg. vol.
352,22 հզր
Volume
89,66 հզր
52-wk high
34,13 $
52-wk low
6,78 $
EPS
-1,67 $
Beta
0,28
Shares outstanding
61,59 մլն
No. of employees
60
Open
7,72 $
High
8,04 $
Low
7,54 $
Mkt. cap
466,87 մլն
Avg. vol.
352,22 հզր
Volume
89,66 հզր
52-wk high
34,13 $
52-wk low
6,78 $
EPS
-1,67 $
Beta
0,28
Shares outstanding
61,59 մլն
No. of employees
60
News stories
From web sources and news partners
About Oculis Holding AG
CEO-
Employees60
Founded2017
HeadquartersZug, Zug, Շվեյցարիա
SectorHealth Care
Industry-
Websiteoculis.com
Analyst ratings
Based on 5 analysts giving stock ratings to OCS in the past 3 months
Strong buy
Buy
5
Hold
0
Sell
0
12-month forecast
Based on 5 Wall Street analysts offering 12 month price targets for OCS in the last 3 months.
Highest
Current 7,54 $
40,00 $ (+430,50%)
Average
34,75 $ (+360,88%)
Lowest
20,00 $ (+165,25%)
Analyst
Recommendation
Action
Price target
Projected
Date
Jason Gerberry
Bank of America Securities
Buy
Maintained
-
-
11/04/2026
Annabel Samimy
Stifel Nicolaus
Buy
Reiterated
40,00 $
+430,5%
11/04/2026
Yatin Suneja
Guggenheim
Buy
Maintained
40,00 $
+430,5%
11/03/2026
Yi Chen
H.C. Wainwright
Buy
Reiterated
39,00 $
+417,2%
11/04/2026
Tessa Romero
J.P. Morgan
Buy
Reiterated
20,00 $
+165,3%
08/14/2026
Patrick Dolezal
LifeSci Capital
Buy
Maintained
41,00 $
+443,8%
08/08/2026
Serge Belanger
Needham
Buy
Maintained
38,00 $
+404%
08/07/2026
Unknown Analyst
Leerink Partners
Buy
Maintained
40,00 $
+430,5%
06/02/2026
Colleen M. Kusy
Robert W. Baird
Buy
Maintained
38,00 $
+404%
06/01/2026
Daniil Gataulin
Chardan Capital
Buy
Reiterated
53,00 $
+602,9%
05/12/2026
Previous reportsAll values in CHF
Loading Previous Earnings...
Revenue
Net income
All values in CHF
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
2026 թ. սեպ
Revenue
411,00 հզր
209,00 հզր
310,00 հզր
7,00 հզր
Cost of goods sold
13,29 մլն
14,05 մլն
15,28 մլն
-
Cost of revenue
13,29 մլն
14,05 մլն
15,28 մլն
-
Research and development expenses
-
-
-
15,05 մլն
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
7,76 մլն
7,89 մլն
8,60 մլն
8,59 մլն
Operating expense
7,76 մլն
7,89 մլն
8,60 մլն
23,64 մլն
Total operating expenses
21,04 մլն
21,94 մլն
23,88 մլն
23,64 մլն
Operating income
-20,63 մլն
-21,73 մլն
-23,57 մլն
-23,64 մլն
Other non operating income
-3,24 մլն
-7,98 մլն
12,10 մլն
3,78 մլն
EBT including unusual items
-23,70 մլն
-28,95 մլն
-9,96 մլն
-18,28 մլն
EBT excluding unusual items
-23,70 մլն
-28,95 մլն
-9,96 մլն
-18,28 մլն
Income tax expense
-182,00 հզր
-98,00 հզր
6,00 հզր
-42,00 հզր
Effective tax rate
0,77%
0,34%
-0,06%
0,23%
Other operating expenses
-
-
-
-
Net income
-23,51 մլն
-28,85 մլն
-9,97 մլն
-18,24 մլն
Net profit margin
-5 721,17%
-13 804,78%
-3 216,13%
-260 514,29%
Earnings per share
-0,42
-0,49
-0,16
-0,30
Interest and investment income
319,00 հզր
367,00 հզր
592,00 հզր
-
Interest expense
-241,00 հզր
-173,00 հզր
-309,00 հզր
-371,00 հզր
Net interest expenses
78,00 հզր
194,00 հզր
283,00 հզր
-371,00 հզր
Depreciation and amortization charges
-
-
-
-
EBITDA
-20,60 մլն
-21,57 մլն
-23,39 մլն
-23,46 մլն
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
Google Apps